BeOne Medicines (ONC) Long-Term Debt Issuances (2015 - 2025)

BeOne Medicines (ONC) has 10 years of Long-Term Debt Issuances data on file, last reported at $26.0 million in Q4 2025.

• On a quarterly basis, Long-Term Debt Issuances rose 187.2% year-over-year to $26.0 million in Q4 2025; TTM through Dec 2025 was $911.0 million, a 9962.96% increase from a year earlier, with the FY2025 full-year figure at $911.0 million, up 9962.96% from the prior year.
• Long-Term Debt Issuances for Q4 2025 stood at $26.0 million, down from $885.0 million in the prior quarter.
• Over the last five years, Long-Term Debt Issuances for ONC reached as high as $885.0 million in Q3 2025 and fell as low as -$22.5 million in Q4 2023.
• Historically, Long-Term Debt Issuances has averaged $81.2 million across 5 years, with a median of $9.1 million in 2024.
• Across the five-year window, Long-Term Debt Issuances tumbled 234.5% in 2024 and surged 9875.76% in 2025, its largest moves.
• Year by year, Long-Term Debt Issuances stood at $6.0 million in 2021, then jumped by 520.9% to $37.4 million in 2022, then slumped by 160.21% to -$22.5 million in 2023, then jumped by 140.23% to $9.1 million in 2024, then surged by 187.2% to $26.0 million in 2025.
• Per Business Quant data, the three most recent Long-Term Debt Issuances figures were $26.0 million in Q4 2025, $885.0 million in Q3 2025, and $9.1 million in Q4 2024.